-
- Oct, 06, 2022
- admin
Exploring avenues Avesthagen set to fire on multiple cylinders, with technologies poised for commercialisation
Avesthagen has developed a slew of technologies at the convergence of food, pharma and population genetics leading to predictive, preventive, personalized healthcare and food security:…
-
- Sep, 08, 2022
- admin
Avesthagen launches new innovative diagnostics platform
Bengaluru-based Avesthagen Limited has launched AVGEN Diagnostics, the first entirely incorporated end-to-end bespoke genetic testing service. The innovative platform employs the most recent in next-generation…
-
- Sep, 07, 2022
- admin
Avesthagen Limited launches AVGEN Diagnostics, an integrated personalised geneti ..
The portfolio addresses cancers, cardiac care diagnostics, neurodegenerative con .. Read more at:https://health.economictimes.indiatimes.com/news/industry/avesthagen-limited-launches-avgen-diagnostics-an-integrated-personalised-genetic-testing-service/94047845
-
- Sep, 06, 2022
- admin
Avesthagen introduces innovative platform for precision diagnostics
Bengaluru-based Avesthagen Limited has launched AVGEN Diagnostics, the first fully integrated end-to-end personalized genetic testing service. The innovative platform employs the latest in next-generation sequencing…
-
- Aug, 11, 2022
- admin
Congenica Partners With Indian Diagnostics Lab for Genomic Analysis, Reporting
NEW YORK – Congenica said Thursday that it has entered into a partnership with Avesthagen to provide genomic analysis and reporting services for the Indian biotechnology company's…
-
- admin
New deal strengthens digital health firm Congenica’s presence in India
UK-based Congenica, a digital health company that enables precision medicine through its world-leading diagnostic decision support platform for genomic data, has partnered with Bengaluru-based Avesthagen,…
-
- Jul, 02, 2022
- admin
The 10,000 Avestagenome Project® leading to population genomics based biomarker discovery
The future of global healthcare is predictive, preventive, precise and based on population genetics. The 10,000 Avestagenome Project® is a systems biology study that aims…
-
- Jun, 22, 2022
- admin
Avesthagen Wipro have launched genetic tests for cancer, neurological disorders, and rare diseases
Wipro's expertise in genomics and biomarker discovery will assist Avesthagen in developing well-regulated workflows during the development of CALiBRx® gene panels. The tests would primarily…
-
- Jun, 21, 2022
- admin
Wipro surges on entering into four-year strategic alliance with Avesthagen
Together, Avesthagen and Wipro will execute the project titled, ‘Cancer Risk Assessed by NGS profiling of Circulating free DNA and RNA for Lung Cancer Project…
-
- Jun, 20, 2022
- admin
Avesthagen launches breakthrough genetic testing portfolio for cancer and other diseases; Enters strategic alliance with Wipro
Meanwhile, the India launch will be followed by expansion in South Asia, Southeast Asia and the MENA region in Q4 2022. Over the next decade,…
UK OFFICE
CORPORATE HEADQUARTERS